EC
ICPT

Elequin Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Elequin Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86
Closed -$1K – 800
2022
Q3 		$1K Sell
86
-814
-90% -$13.1K ﹤0.01% 545
2022
Q2 		$12K Buy
900
+23
+3% +$368 ﹤0.01% 226
2022
Q1 		$14K Buy
+877
New +$13.7K ﹤0.01% 149

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Elequin Capital's ICPT Position: Q4 2022 in Review

Elequin Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 86 shares — an estimated $1K sold.

Elequin Capital first reported a position in ICPT in Q1 2022 and held it in 3 quarters. The position peaked at $14K in Q1 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

  • Elequin Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Elequin Capital sold 86 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1K.
  • Elequin Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 3 quarters.
  • Elequin Capital's Intercept Pharmaceuticals, Inc. position peaked at $14K in Q1 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.